A standard test was designed for measurement of the effect of epinephrine infusion on systolic time intervals in 14 normal subjects as a dose-response phenomenon. In order that we might examine the sensitivity of the test, it was applied in nine patients with idiopathic hypertrophic subaortic stenosis.
S TUDIES dealing with the interaction of the sympathetic nervous system and the heart are hampered by: (a) the technical difficulty of the measurement of plasma catecholamines and (b) the unknown physiologic significance of these measurements. Estimation of end-organ (myocardial) sensitivity might prove to be a useful tool for the study of these interactions. The systolic time intervals standardized by Weissler are atraumatic and easily reproducible. They offered a parameter for measurement of this response.
We have measured the systolic time intervals of normal individuals during graded epinephrine infusions, thereby establishing the effects of sympathetic stimulation upon cardiovascular dynamics as a dose-response curve. In order to examine the sensitivity of the test, we studied nine patients with idiopathic hypertrophic subaortic stenosis (IHSS). The results show that the epinephrine infusion test is capable of identifying an abnormal response in this clinical entity, and, in addition, it can detect the normalization of response that occurs with reinfusion of epinephrine after beta blockade.
Materials and Methods
The study population consisted of 14 normal males (mean age 25; range 17-41 years) and nine patients with IHSS (six males, three females; mean age 38; range 18-54 years).
The normal subjects were evaluated by detailed cardiovascular history, physical examination, chest X-ray, and resting electrocardiogram. In all nine patients, the diagnosis of IHSS was 137 In order to define experimentally the effect of a change in heart rate, alone, on the systolic time intervals, we measured the systolic time intervals in the cardiac catheterization laboratory during right atrial pacing at various heart rates in four normal subjects.
Measurements
The Q2 interval was measured from the onset of the QRS complex of the electrocardiogram to the first high frequency component of the second heart sound. Left ventricular ejection time (LVET) was measured from the carotid pulse as the interval from the onset of the upstroke to the trough of the incisura. The pre-ejection period (PEP) was calculated by subtraction of the LVET from the Q2 interval. The PEP/LVET ratio was calculated and expressed as a per cent.
To minimize beat-to-beat variation, we measured systolic time intervals at end-expiration. The ejection time intervals of one cardiac cycle was determined to be an accurate sample (coefficient of variability less than 1%) of all the cardiac cycles, hence only one cycle was measured.
Results were expressed both in absolute terms (msee) and corrected for heart rate as the per cent of the expected value for the observed heart rate. Mean, standard deviation, and standard error of the mean were calculated by standard statistical methods. 2 Differences in the same subject before and after a change in state were tested for significance by the t-test for paired samples. Differences between normal subjects and patients with IHSS were tested for significance by the t-test for unpaired samples. Figure 1 The effect of graded epinephrine infusion on the systolic tinm intervals of normal subjects. represents the mean + SEM for heart rate and systolic time interval. The epinephrine infusion rate is noted to -he right of each marker.
Results

Normal Subjects Epinephrine Infusion Test
See figure 1 (fig. 2 ). The PEP decreased from 87.4 3.6 to 44.8 + 3.8% of the expected value (P < 0.001), whereas the LVET did not change significantly.
Coexistent with these changes in hemodynamics ( fig. 3) , the first heart sound in each normal subject became progressively louder. A third or fourth heart sound appeared, or if it were present in the control tracings, became louder. A systolic murmur developed in all subjects. Premature beats occurred infrequently. Various emotional states including anxiety, fear, and elation were experienced by normal subjects. Most were aware that their heart beat faster, but none complained of chest pain. None experienced uncontrollable emotional lability as has been reported by Frohlich. 3 Epinephrine reinfusion after beta blockade in two normal subjects resulted in a slowing of The effect of graded epinephrine infusion on the systolic time intervals corrected for heart rate in normal subjects. Note the marked shortening of PEP with little change of LVET.
the heart rate with no change in the LVET corrected for heart rate. Epinephrine administration resulted in a progressive rise in heart rate from 76.1 + 3.5 to 95.1 + 4.7 beats/min, (P < 0.01) (table 3). There was no significant change in either the systolic or the diastolic blood pressure.
There was shortening of the PEP from 93.0 + 6.2 to 62.8 + 7.3 msec, (P < 0.01). The LVET and Q2 initially lengthened at low epinephrine infusion rates and then shortened.
When corrected for changes in heart rate, the PEP shortened from 92.7 ± 6.9 to 68.1 ± 8.6% of the expected value (P <0.01). The LVET lengthened maximally from 113.0 + 3.8 to 123.9 + 4.5% of the expected value (P < 0.02), at an epinephrine infusion rate of 0.02 ,ug/kg/min. The effect of epinephrine infusion (0.10 ,ug/kg/min) on the phonocardiogram. The rate is more rapid; Si increases in intensity; S. and S4 appear, and an early systolic murmur develops.
The phonocardiographic correlates were the same in the patients with IHSS as in the normal subjects except that most of the patients with IHSS had a systolic murmur during the control record, which increased in intensity with increasing epinephrine infusion rates ( fig. 5) .
Eight of the nine patients experienced chest pain at an epinephrine infusion rate of 0.06 ,ug/kg/min. One patient (E.R.) experienced chest pain and dyspnea at an epinephrine infusion rate of 0.03 ,ig/kg/min. In all patients the chest pain and/or dyspnea were relieved within minutes after epinephrine infusion was discontinued and propranolol (0.1 mg/kg) was administered.
Epinephrine Infusion Test after Administration of Propranolol
After beta blockade (with propranolol) the baseline systolic time intervals corrected for heart rate were not significantly different from the control measurements before blockade (table 3 and fig. 6 ). Reinfusion of epinephrine resulted in a decrease in heart rate and LVET corrected for heart rate, and both the systolic and diastolic blood pressures increased.
Differences Figure 5 An unusual example of a patient with idiopathic hypertrophic subaortic stenosis who had no murmur and a normal carotid pulse during the control record. With epinephrine infusion (0.06 ,ug/kg/min), a harsh systolic murmur and characteristic carotid pulse tracing appeared. The control tracing after administration of propranolol resembled the record before propranolol was given. After administration of propranolol, reinfusion of epinephrine resulted in a slower heart rate, softer S1, and normal phonocardiogram and carotid pulse tracing. to 94.9 0.9% of the expected value (P< 0.01). Also in agreement with the data of Harris were the results of reinfusion of epinephrine after beta blockade in normal subjects. This was characterized by progressive bradyeardia with increasing epinephrine infusion rates. However, there was no change in the LVET corrected for heart rate. The mechanism for this response was probably peripheral arterial constriction (an unopposed alpha-adrenergic effect) producing reflex bradyeardia.
Right atrial pacing, alone, produced no shortening of the PEP over a wide range of heart rates in any normal subject studied. This agrees with data reported in patients with organic heart disease.5 These data imply that the shortening of PEP produced by epinephrine is a function of increased performance of the myocardium unrelated to the increase in heart rate,6 i.e., it reflects the inotropic rather than the chronotropic influence of the drug.
The patients with IHSS had an abnormally long resting mean LVET, presumably reflect-ing the left ventricular outflow obstruction. 7 The response of these patients to epinephrine infusion differed qualitatively from that of normal subjects. Although the heart rate increased, the LVET lengthened (normal subjects had shorter LVET with tachycardia). This was most marked at low epinephrine infusion rates (0.02 gg/kg/min). Three of the patients with IHSS had normal systolic time intervals at rest. Provocation by epinephrine infusion was needed for demonstration of the abnormality.
Propranolol reversed the paradoxical response to epinephrine. After beta blockade, increasing epinephrine infusion rates resulted in progressive shortening of the LVET, probably indicating diminished obstruction of left ventricular outflow.
This study emphasizes the practicality of these relatively simple methods in evaluation of left ventricular function. We have standardized an epinephrine infusion test in normal subjects and have applied it in patients with IHSS. The test is capable of demonstrating the epinephrine-induced exacerbation of this syndrome and the prevention of this effect after beta blockade.
This relatively simple test, a bioassay of the results of epinephrine administration on the left ventricular function, may offer a tool for study of the interaction of the sympathetic nervous system and the heart.
